Hypertension after pediatric cardiac transplantation: detection, etiology, implications and management

S Lucy Roche1, John J O'Sullivan, Paul F Kantor

  • 1Department of Pediatric Cardiology, The Hospital for Sick Children, Toronto, ON, Canada.

Insights

Pediatric heart transplant recipients often develop hypertension, a serious complication impacting survival. This review explores causes, monitoring, and treatment of this condition in children post-transplant.

Area of Science:

  • Pediatric Cardiology
  • Transplant Medicine
  • Hypertension Research

Background:

  • Cardiac transplantation is life-saving for children with end-stage heart failure.
  • A significant majority (50-70%) of pediatric recipients develop new-onset hypertension post-transplant.
  • Uncontrolled hypertension poses risks to graft and patient survival due to vulnerable heart and kidney systems.

Purpose of the Study:

  • To review the multi-factorial etiology of post-transplant hypertension in pediatric cardiac recipients.
  • To highlight current uncertainties and specific mechanisms of hypertension in this population.
  • To discuss optimal blood pressure (BP) monitoring and treatment strategies.

Main Methods:

  • Literature review focusing on post-cardiac transplant hypertension in children.
  • Analysis of etiological factors, monitoring techniques, and therapeutic interventions.
  • Emphasis on mechanisms unique to cardiac recipients and specific treatment cautions.

Main Results:

  • Post-transplant hypertension is a common and serious complication in pediatric cardiac recipients.
  • Multiple factors contribute to hypertension, with specific mechanisms requiring further investigation.
  • 24-hour ambulatory blood pressure (ABP) monitoring offers advantages over intermittent clinic measurements.
  • Antihypertensive prescribing requires specific cautions in this vulnerable population.

Conclusions:

  • Effective management of post-transplant hypertension is crucial for improving long-term outcomes in pediatric cardiac recipients.
  • Further research is needed to fully elucidate the multifactorial etiology and optimize treatment.
  • Close monitoring, particularly using 24-hour ABP, and careful medication selection are essential.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...